BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 19182775)

  • 1. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
    Zheng Y; Chaudhry A; Kas A; deRoos P; Kim JM; Chu TT; Corcoran L; Treuting P; Klein U; Rudensky AY
    Nature; 2009 Mar; 458(7236):351-6. PubMed ID: 19182775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression.
    Wan YY; Flavell RA
    Nature; 2007 Feb; 445(7129):766-70. PubMed ID: 17220876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Foxp3 function and expression in the thymic epithelium.
    Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
    J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.
    Zheng Y; Josefowicz S; Chaudhry A; Peng XP; Forbush K; Rudensky AY
    Nature; 2010 Feb; 463(7282):808-12. PubMed ID: 20072126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Foxp3 enhancers synergize to maximize regulatory T cell suppressive capacity.
    Zong X; Hao X; Xu B; Crawford JC; Wright S; Li J; Zhang Y; Bai L; He M; Jiang M; Fan Y; Connelly JP; Pruett-Miller SM; Berns H; Janke L; Li C; Feng Y
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34086055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.
    Darce J; Rudra D; Li L; Nishio J; Cipolletta D; Rudensky AY; Mathis D; Benoist C
    Immunity; 2012 May; 36(5):731-41. PubMed ID: 22579475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells.
    Fu W; Ergun A; Lu T; Hill JA; Haxhinasto S; Fassett MS; Gazit R; Adoro S; Glimcher L; Chan S; Kastner P; Rossi D; Collins JJ; Mathis D; Benoist C
    Nat Immunol; 2012 Oct; 13(10):972-80. PubMed ID: 22961053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TCR repertoire and Foxp3 expression define functionally distinct subsets of CD4+ regulatory T cells.
    Kuczma M; Pawlikowska I; Kopij M; Podolsky R; Rempala GA; Kraj P
    J Immunol; 2009 Sep; 183(5):3118-29. PubMed ID: 19648277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 expression positively correlates with Foxp3 expression and suppressive function of CD4+ Treg cells.
    Liu T; Soong L; Liu G; König R; Chopra AK
    Biol Direct; 2009 Oct; 4():40. PubMed ID: 19852824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?
    Beyer M; Schultze JL
    Int Immunopharmacol; 2011 May; 11(5):555-60. PubMed ID: 21115121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation.
    Nayar R; Enos M; Prince A; Shin H; Hemmers S; Jiang JK; Klein U; Thomas CJ; Berg LJ
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):E2794-802. PubMed ID: 23011795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells.
    Haxhinasto S; Mathis D; Benoist C
    J Exp Med; 2008 Mar; 205(3):565-74. PubMed ID: 18283119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Ets-1 transcription factor controls the development and function of natural regulatory T cells.
    Mouly E; Chemin K; Nguyen HV; Chopin M; Mesnard L; Leite-de-Moraes M; Burlen-defranoux O; Bandeira A; Bories JC
    J Exp Med; 2010 Sep; 207(10):2113-25. PubMed ID: 20855499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Mutation in the Transcription Factor Foxp3 Drives T Helper 2 Effector Function in Regulatory T Cells.
    Van Gool F; Nguyen MLT; Mumbach MR; Satpathy AT; Rosenthal WL; Giacometti S; Le DT; Liu W; Brusko TM; Anderson MS; Rudensky AY; Marson A; Chang HY; Bluestone JA
    Immunity; 2019 Feb; 50(2):362-377.e6. PubMed ID: 30709738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory T cell development in the absence of functional Foxp3.
    Lin W; Haribhai D; Relland LM; Truong N; Carlson MR; Williams CB; Chatila TA
    Nat Immunol; 2007 Apr; 8(4):359-68. PubMed ID: 17273171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Foxp3 occupancy and regulation of key target genes during T-cell stimulation.
    Marson A; Kretschmer K; Frampton GM; Jacobsen ES; Polansky JK; MacIsaac KD; Levine SS; Fraenkel E; von Boehmer H; Young RA
    Nature; 2007 Feb; 445(7130):931-5. PubMed ID: 17237765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3-deficient regulatory T cells do not revert into conventional effector CD4+ T cells but constitute a unique cell subset.
    Kuczma M; Podolsky R; Garge N; Daniely D; Pacholczyk R; Ignatowicz L; Kraj P
    J Immunol; 2009 Sep; 183(6):3731-41. PubMed ID: 19710455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.
    Tritt M; Sgouroudis E; d'Hennezel E; Albanese A; Piccirillo CA
    Diabetes; 2008 Jan; 57(1):113-23. PubMed ID: 17928397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL4 blockade of inducible regulatory T cell differentiation: the role of Th2 cells, Gata3 and PU.1.
    Hadjur S; Bruno L; Hertweck A; Cobb BS; Taylor B; Fisher AG; Merkenschlager M
    Immunol Lett; 2009 Jan; 122(1):37-43. PubMed ID: 19046990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrathymically generated regulatory T cells control mucosal TH2 inflammation.
    Josefowicz SZ; Niec RE; Kim HY; Treuting P; Chinen T; Zheng Y; Umetsu DT; Rudensky AY
    Nature; 2012 Feb; 482(7385):395-9. PubMed ID: 22318520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.